These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15932036)

  • 1. [New therapeutic perspectives in Sjögren syndrome: leflunomide].
    Scagliusi P; Minenna G; D'Amore M; Scagliusi A
    Recenti Prog Med; 2005 Apr; 96(4):194. PubMed ID: 15932036
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus erythematosus with leflunomide: induction or reactivation?
    Gensburger D; Kawashima M; Marotte H; Kanitakis J; Miossec P
    Ann Rheum Dis; 2005 Jan; 64(1):153-5. PubMed ID: 15608317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.
    Meijer JM; Pijpe J; Vissink A; Kallenberg CG; Bootsma H
    Ann Rheum Dis; 2009 Feb; 68(2):284-5. PubMed ID: 19139205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological studies of the parotid gland in the immunosuppressive therapy of Sjögren's syndrome].
    Donath K; Pirsig W
    Verh Dtsch Ges Rheumatol; 1974; 3(0):277. PubMed ID: 4839655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppression in Sjogren's syndrome with a pseudo-leukemic lymphocyte reaction].
    Orlowski Z; Jedrzejewska T
    Pol Tyg Lek; 1970 Oct; 25(42):1588-9. PubMed ID: 5476524
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of immunosuppressive drugs on the morphology of the microvilli in Sjögren's syndrome.
    Scharf JM; Meyer E; Scharf JA; Nahir M; Zonis S
    Scand J Rheumatol Suppl; 1986; 61():215-9. PubMed ID: 3473634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sjögren's syndrome: therapeutic trends].
    Di Giacinto G; Piergiacomi G
    Clin Ter; 1991 Nov 15-30; 139(3-4):81-92. PubMed ID: 1837255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.
    van Woerkom JM; Kruize AA; Geenen R; van Roon EN; Goldschmeding R; Verstappen SM; van Roon JA; Bijlsma JW
    Ann Rheum Dis; 2007 Aug; 66(8):1026-32. PubMed ID: 17223657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sjögren's syndrome].
    Schmidt RE; Witte T; Dörner T
    Z Rheumatol; 2010 Feb; 69(1):9-10. PubMed ID: 20012973
    [No Abstract]   [Full Text] [Related]  

  • 12. Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome.
    Kaufman I; Schwartz D; Caspi D; Paran D
    Scand J Rheumatol; 2008; 37(3):213-8. PubMed ID: 18465457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome with extremely elevated plasma alpha-fetoprotein that responded to immunosuppressant treatment.
    Ye LJ; Wang ZY; Zhang X
    Chin Med J (Engl); 2012 Nov; 125(21):3916-7. PubMed ID: 23106900
    [No Abstract]   [Full Text] [Related]  

  • 14. Prominent adverse effects of thalidomide in primary Sjögren's syndrome.
    Pillemer SR; Leakan RA; Sankar V; Manny J; Baum BJ; Smith J; Chaudhry U; Fox PC; Radfar L; Ligier S; Brennan MT
    Arthritis Rheum; 2004 Jun; 51(3):505-6. PubMed ID: 15188341
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Original therapeutic endeavor for the Gougerot-Sjögren syndrome].
    Bonnet M; Moulin J; Girod M; Gouillon L; Biard L
    Bull Soc Ophtalmol Fr; 1969; 69(5-6):615-22. PubMed ID: 5399676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sjögren's syndrome in childhood. Description of a clinical case].
    Cottafava F; Cosso D; Faraci M; Carpi A; Lombardi J
    Minerva Pediatr; 1990 Nov; 42(11):499-501. PubMed ID: 2082178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodistributed eruption with rhabdomyolisis due to leflunomide.
    Adamski H; Lopez L; Polard E; Chevrant-Breton J; Dupuy A
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):222-3. PubMed ID: 21729173
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclophosphamide treatment of parotid swelling in Sjögren syndrome].
    Aliaga L; Quiroga J; Prieto J
    Med Clin (Barc); 1984 Jun; 83(5):222-3. PubMed ID: 6482585
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of ocular surface inflammation in Sjögren syndrome.
    Hyon JY; Lee YJ; Yun PY
    Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.